Title Contemporary issues for protecting patients in cancer research : workshop summary / Sharyl J. Nass and Margie Patlak, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies

Published Washington, D.C. : National Academies Press, [2014] ©2014

Click on the following:
ProQuest Ebook Central

Copies

Description 1 online resource (xvii, 74 pages) : illustrations Series Online access: National Academy of Sciences National Academies Press Online access: NCBI NCBI Bookshelf Contents Introduction -- Current regulatory arena -- Common rule and HIPAA -- Shortcomings of current regulations and guidances -- Context -- Data deindentification -- Impediment to quality improvement and learning -- Varied interpretation -- Misaligned incentives -- Lack of harmonization with international standards -- Informed consent forms -- Informed consent process -- Consent tools -- Beyond consent -- HITECH -- Advanced notice of proposed rulemaking -- Patient perspectives on research protections -- Ethical challenges of genetic advances -- Patient consent for use of archived biospecimens -- Return of research results -- Clinically actionable findings -- Context matters -- Who pays -- Biospecimens from deceased participants -- The changing context of research and care -- Oversight in a learning health care system -- Oversight of pragmatic trials -- Multisite studies and IRB review -- Central IRBs -- New England Reliance Agreement -- Value of local IRBs -- Educational needs -- Research needs -- Wrap-up Summary "In the nearly 40 years since implementation of federal regulations governing the protection of human participants in research, the number of clinical studies has grown exponentially. These studies have become more complex, with multisite trials now common, and there is increasing use of archived biospecimens and related data, including genomics data. In addition, growing emphasis on targeted cancer therapies requires greater collaboration and sharing of research data to ensure that rare patient subsets are adequately represented. Electronic records enable more extensive data collection and mining, but also raise concerns about the potential for inappropriate or unauthorized use of data, bringing patient protections into a new landscape. There are also long-standing concerns about the processes and forms used to obtain informed consent from patients participating in clinical studies. These changes and challenges raise new ethical and practical questions for the oversight of clinical studies, and for protecting patients and their health information in an efficient manner that does not compromise the progress of biomedical research. Contemporary Issues for Protecting Patients in Cancer Research is the summary of a workshop convened by the National Cancer Policy Forum of the Institute of Medicine in February 2014 to explore contemporary issues in human subjects protections as they pertain to cancer research, with the goal of identifying potential relevant policy actions. Clinical researchers, government officials, members of Institutional Review Boards, and patient advocates met to discuss clinical cancer research and oversight. This report examines current regulatory provisions that may not adequately protect patients or may be hindering research, and discusses potential strategies and actions to address those challenges"--Publisher's description Bibliography Includes bibliographical references Notes Online resource; title from resource home page (National Academies Press, viewed September 23, 2014) Subject Human experimentation in medicine -- United States -- Congresses Human experimentation in medicine -- Moral and ethical aspects -- United States -- Congresses Patients -- Civil rights -- United States -- Congresses Clinical trials -- United States -- Congresses Cancer -- Research -- United States -- Congresses Medical ethics -- United States -- Congresses Informed consent (Medical law) Institutional review boards (Medicine) Clinical Trials as Topic -- standards Human Experimentation -- standards -- United States -- Congresses Patient Rights -- United States -- Congresses Neoplasms -- United States -- Congresses Ethics, Research -- United States -- Congresses Ethics Committees, Research -- United States -- Congresses Informed Consent -- United States -- Congresses Research Subjects -- United States -- Congresses Confidentiality -- standards -- United States -- Congresses Electronic Health Records -- standards -- United States -- Congresses Privacy -- United States -- Congresses Researcher-Subject Relations -- United States -- Congresses Clinical Trials as Topic -- standards -- United States -- Congresses Researcher-Subject Relations Informed Consent Ethics Committees, Research Confidentiality -- standards Electronic Health Records -- standards Privacy Patient Rights Neoplasms Ethics, Research Human Experimentation -- standards Research Subjects Truth Disclosure BUSINESS & ECONOMICS -- Business Ethics. Institutional review boards (Medicine) Informed consent (Medical law) Cancer -- Research Clinical trials Human experimentation in medicine Human experimentation in medicine -- Moral and ethical aspects Medical ethics Patients -- Civil rights United States United States Genre/Form proceedings (reports) Conference papers and proceedings Conference papers and proceedings. Actes de congrès. Form Electronic book Author Nass, Sharyl J., rapporteur. Patlak, Margie, rapporteur. National Cancer Policy Forum (U.S.), issuing body. ISBN 9780309306676 0309306671

Other Titles Protecting patients in cancer research

  Permalink